TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $89.83M2014: $120.46M2015: $219.31M2016: $159.13M2017: $132.08M2018: $138.06M2019: $303.71M2020: $560.67M2021: $581.61M2022: $618.26M2023: $823.03M2024: $580.52M2025: $197.33M$197.33M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$197.33M-66.0%
2024$580.52M-29.5%
2023$823.03M+33.1%
2022$618.26M+6.3%
2021$581.61M+3.7%
2020$560.67M+84.6%
2019$303.71M+120.0%
2018$138.06M+4.5%
2017$132.08M-17.0%
2016$159.13M-27.4%
2015$219.31M+82.1%
2014$120.46M+34.1%
2013$89.83M—